Join our growing community to challenge mainstream media bias and fix the news
Gilead Sciences to start testing inhaled version of remdesivir

Gilead Sciences to start testing inhaled version of remdesivir

Gilead Sciences will begin human trials for an inhaled version of its antiviral drug remdesivir in August. The drug has shown promise in the treatment of COVID-19. While patients currently get doses of remdesivir through IV drips, an inhaled form of the drug could be delivered through a nebulizer, which would make it easier to administer outside of hospitals at earlier stages of infection.

KCooper
KCooper
Spontaneous Order
Spontaneous Order 3 months

Is this the under-performing Fauci drug? The same Fauci who's gov't agency pumped research grants into the Wuhan lab? The corruption in the US government is astounding.

Top in Business